148 related articles for article (PubMed ID: 5674913)
1. Action of thyroxine and calcitonin on experimental soft-tissue calcification.
Gabbiani G; Tuchweber B; Côté G; Lefort P
Calcif Tissue Res; 1968 Jul; 2(1):30-7. PubMed ID: 5674913
[No Abstract] [Full Text] [Related]
2. Interactions of parathyroid hormone, thyroxine and calcitonin.
Gabbiani G; Tuchweber B; Côté G
Calcif Tissue Res; 1968; ():Suppl:76. PubMed ID: 4305496
[No Abstract] [Full Text] [Related]
3. [Effect of thyrocalcitonin on experimental soft tissue calcinosis].
Altenähr E; Schäfer HJ; Wulff CA
Virchows Arch A Pathol Pathol Anat; 1970; 349(2):124-37. PubMed ID: 5316665
[No Abstract] [Full Text] [Related]
4. Roles of thyroxine and thyrocalcitonin in the response to hypercalcemia in rats.
Gittes RF; Irvin GL
Endocrinology; 1966 Dec; 79(6):1033-9. PubMed ID: 5927706
[No Abstract] [Full Text] [Related]
5. Protective effect of thyrocalcitonin against nephrocalcinosis induced by parathyroid hormone in rats.
Peng TC
Mol Cell Endocrinol; 1974 Dec; 2(1):1-15. PubMed ID: 4455529
[No Abstract] [Full Text] [Related]
6. Effect of thyrocalcitonin and thyroxine on experimental metastatic calcification.
Côté G; Gabbiani G; Tuchweber B; Déziel C
Acta Endocrinol (Copenh); 1968 Nov; 59(3):362-70. PubMed ID: 5754977
[No Abstract] [Full Text] [Related]
7. [Therapy of osteodystrophia deformans (Paget's disease)].
Jesserer H
Clin Ter; 1974 Jun; 69(6):501-15. PubMed ID: 4367627
[No Abstract] [Full Text] [Related]
8. Biochemical studies on the anticalcinotic effect of sodium salicylate.
Berczi I; Somogyi A
Can J Physiol Pharmacol; 1969 Jul; 47(7):597-601. PubMed ID: 5801355
[No Abstract] [Full Text] [Related]
9. Ability of thyrocalcitonin to protect against hypercalcemia in adult rats.
Harper C; Toverud SU
Endocrinology; 1973 Dec; 93(6):1354-9. PubMed ID: 4752885
[No Abstract] [Full Text] [Related]
10. [Humoral mechanisms in neoplastic hypercalcemia].
Gennari C; Montagnani M; Nami R; Francini G
Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
[No Abstract] [Full Text] [Related]
11. [Recent findings on thyrocalcitonin and parathyroid hormone].
Kohler H; Wernly M
Schweiz Med Wochenschr; 1969 May; 99(20):740-3. PubMed ID: 4891579
[No Abstract] [Full Text] [Related]
12. Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis.
Zhao L; Huang L; Zhang X
Rheumatol Int; 2016 Jul; 36(7):1023-6. PubMed ID: 27136920
[TBL] [Abstract][Full Text] [Related]
13. Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat.
Cooper CW; Hirsch PF; Munson PL
Endocrinology; 1970 Feb; 86(2):406-15. PubMed ID: 5409935
[No Abstract] [Full Text] [Related]
14. Effect of sodium pyrophosphate on experimental soft-tissue calcification and hypercalcemia.
Tuchweber B; Gabbiani G
Can J Physiol Pharmacol; 1967 Nov; 45(6):957-64. PubMed ID: 4294212
[No Abstract] [Full Text] [Related]
15. Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D.
Mittleman R; Chausmer A; Bellavia J; Wallach S
Endocrinology; 1967 Sep; 81(3):599-604. PubMed ID: 4291806
[No Abstract] [Full Text] [Related]
16. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.
Alon U; Berkowitz D; Berant M
Child Nephrol Urol; 1992; 12(1):47-50. PubMed ID: 1606583
[TBL] [Abstract][Full Text] [Related]
17. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of calcitriol in hemodialysis patients.
Baker LR; Muir JW; Sharman VL; Abrams SM; Greenwood RN; Cattell WR; Goodwin FJ; Marsh FP; Adami S; Hately W
Clin Nephrol; 1986 Oct; 26(4):185-91. PubMed ID: 3536232
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hypercalcaemic nephropathy and tissue calcification by glucagon during phosphate infusion.
Condon JR; Cross JA; Yones A
Med Hypotheses; 1999 Jul; 53(1):45-7. PubMed ID: 10499824
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes.
Dopplet SH; Talmage RV
Clin Orthop Relat Res; 1976; (118):242-50. PubMed ID: 954281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
